Clinical Trials Browser

Phase 2 × Breast Carcinoma In Situ × Lovastatin × Clear all

NCT00902668 2013-06-20

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Phase 2 Terminated

3 enrolled 4 charts

Breast Carcinoma In Situ, Breast Neoplasms, Radiation Injuries